Supporting Front Line Workers: Why Weight Loss Solutions Must Be Customizable
by CalibrateMarch 18, 2026
You’ve heard the brand name in the news: Ozempic® (semaglutide) is an FDA-approved GLP-1 medication indicated for managing type-2 diabetes and proven to support weight loss. If you’re prescribed Ozempic®, understanding how to properly administer the injection is key for ensuring safety and effectiveness.
The information in this article also applies for pre-filled pens of Wegovy® (semaglutide), Mounjaro® (tirzepatide), Zepbound® (tirzepatide), and certain other GLP-1 medications. These are just a few of the medications prescribed—where clinically appropriate and insurance eligible—by Calibrate clinicians for Calibrate members.
In this guide, we’ll cover everything you need to know about how to inject Ozempic®, including injection sites, how to inject Ozempic® in your stomach, thigh, or upper arm, and important safety information.
Am I eligible for Calibrate? Take the quiz.
Ozempic® is a once-weekly injectable medication that comes in a prefilled pen. The medication is injected under the skin (subcutaneous injection), and typical injection sites include the stomach (abdomen), thigh, or upper arm.
Once prescribed Ozempic® or a similar GLP-1 medication by your Calibrate clinical team, you’ll have a chance to ask questions or voice any concerns you might have about self-injecting with your team. But know that—while it can be intimidating at first—Ozempic® and other pre-filled GLP-1 pens are designed to be easy to use.
Most patients catch on within a matter of weeks and experience very little discomfort during the injection. That’s because the pens use ultra-fine needles, and the shot does not go as deep as, say, a flu shot: It only enters the fat layer, not the muscle beneath.
Here’s a breakdown of the steps for administering Ozempic® correctly, adapted from the manufacturer, Novo Nordisk:
Prefer to watch a video for injection help? Watch this “How to inject with your injection pen?” video published by Ozempic® manufacturer Novo Nordisk.
The most common injection site options for GLP-1 medications are the stomach, the thigh, and the upper arm. If you need other alternatives for any reason, talk to your Calibrate clinician or the health professional who prescribes your medication.
You can expect similar results no matter where you inject Ozempic®. While some research shows slightly lower absorption when injected in the thigh compared to the stomach, this difference isn't considered significant.
Overall, injection sites—thigh, stomach, or upper arm—are interchangeable. Choose the site that feels most comfortable for you.
Other factors, like body weight and whether or not you have type-2 diabetes, may also affect how your body absorbs Ozempic®—but more research is needed to fully understand these differences.
The stomach is one of the most common injection sites for Ozempic®. To inject Ozempic® in your stomach:
Injecting in your stomach tends to be convenient for many users because the skin is easily accessible and you can keep an eye on the injection process.
Injecting Ozempic® in your thigh can be an alternative if you prefer to rotate your injection sites. To inject in the thigh:
If you're comfortable or need assistance, the outer upper arm is another injection site. However, this area can be more difficult to reach by yourself, so you may require help from someone else to inject properly.
Like all medications, Ozempic® (semaglutide) may cause side effects. Common side effects include:
Rare but serious side effects may include the risk of thyroid cancer and pancreatitis. If you experience symptoms like severe stomach pain, swelling in your neck, or difficulty swallowing, seek medical attention right away.
While knowing how to inject Ozempic® (semaglutide) correctly is essential for using the medication effectively, successful, sustained weight loss and metabolic health improvements require more than just administering the injection. This is where the Calibrate Metabolic Reset program sets itself apart.
At Calibrate, we combine clinically proven GLP-1 medications like Ozempic® with coaching and guidance to make sure you enact the lifestyle changes necessary to sustain your weight loss. Our program is rooted in creating small but meaningful changes in areas like food, activity, sleep, and—importantly—emotional health.
Simply taking medication without addressing underlying metabolic factors often leads to short-term results. The Calibrate program helps you make lasting changes by pairing medication with a comprehensive, evidence-based curriculum and one-on-one support from your Calibrate accountability coach.
Your Calibrate coaching team will support you in optimizing your diet, exercise, sleep, and emotional health—the Four Pillars of Metabolic Health—to achieve sustainable weight loss. While Ozempic® (semaglutide) can support your weight loss efforts, research shows that combining medication with lifestyle changes yields the best results.
Calibrate’s holistic approach to weight loss ensures that you’re not just managing symptoms but improving your overall metabolic health for long-term success.
Knowing how to inject Ozempic® (semaglutide) correctly ensures that you’re getting its full benefits for blood sugar regulation and metabolic support.
You can inject Ozempic® in your upper arm, stomach, or thigh; the site you choose should not have a significant impact on how well the medication works. Pick whichever is most comfortable to you.
Remember to rotate injection sites, store your pen properly, and follow the instructions provided by your clinician. As a Calibrate member, you can reach out to your clinical team with questions anytime via the Calibrate app.
Ready to take the first step? Join Calibrate today and start your journey to lasting, sustainable weight loss.
We’re a modern, medical approach that combines clinician-prescribed medication with 1:1 accountability coaching—all personalized to your biology, your goals, and your life for a metabolic reset that lasts and 10% Weight Loss Guaranteed (see terms).
See All from Calibrate
by CalibrateMarch 18, 2026